Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Times Interest Earned (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Times Interest Earned for 6 consecutive years, with -$587.39 as the latest value for Q3 2025.

  • On a quarterly basis, Times Interest Earned fell 470.16% to -$587.39 in Q3 2025 year-over-year; TTM through Sep 2025 was -$457.19, a 11671.38% decrease, with the full-year FY2024 number at -$5.22, up 82.78% from a year prior.
  • Times Interest Earned was -$587.39 for Q3 2025 at Ensysce Biosciences, down from -$553.96 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $542.0 in Q2 2022 to a low of -$1710.9 in Q1 2023.
  • A 5-year average of -$310.87 and a median of -$195.34 in 2024 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: tumbled 36470.33% in 2021, then soared 119676.99% in 2022.
  • Ensysce Biosciences' Times Interest Earned stood at -$20.59 in 2021, then surged by 730.77% to $129.85 in 2022, then plummeted by 107.05% to -$9.15 in 2023, then plummeted by 3534.11% to -$332.6 in 2024, then tumbled by 76.6% to -$587.39 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Times Interest Earned are -$587.39 (Q3 2025), -$553.96 (Q2 2025), and -$510.25 (Q1 2025).